FTC-133 (人滤泡状甲状腺癌细胞) (STR鉴定正确)

一键复制产品信息

参考文献

• SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway (2023-09-08)

  作者：Jiancang Ma:1.Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China. ; Xin Huang:1.Department of General Surgery, Xi'an Central Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, 710003, China. ; Jinkai Xu:1.Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China. ; Zongyu Li:1.Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China. ; Jingyue Lai:1.Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China. ; Yawei Shen:1.Department of General Surgery, Xi'an Central Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, 710003, China. ; Jun Zhao:1.Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China. ; Xuejun Sun:1.Department of General Surgery, The Fi

  期刊：SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway

  DOI：10.1186/s10020-023-00700-y

  影响因子 ：5.7

  引用产品： FTC-133 细胞 ,  人视网膜微血管内皮细胞

• Circ_0124055 promotes the progression of thyroid cancer cells through the miR-486-3p/MTA1 axis (2023-01-05)

  作者：Z Chen:1.Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China. ; Y Su:1.Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China. ; D Peng:1.Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China. ; W Wang:1.Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China. ; J Zhong:1.Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China. ; A Zhou:1.Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China. ; L Tan:1.Department of Nuclear Medicine, The Second Affiliated Hospital of Nanchang University, No.1 Minde Road, Nanchang, 330006, Jiangxi, China. tll_654321@163.com. ;

  期刊：Circ_0124055 promotes the progression of thyroid cancer cells through the miR-486-3p/MTA1 axis

  DOI：10.1007/s40618-022-01998-x

  影响因子 ：5.4

  引用产品： TPC-1 细胞 ,  FTC-133 细胞 ,  SW579 [SW 579; SW-579] 细胞 ,  293T [HEK-293T] 细胞

• Ultrasound-targeted microbubble destruction-mediated miR-144-5p overexpression enhances the anti-tumor effect of paclitaxel on thyroid carcinoma by targeting STON2 (2002-02-20)

  作者：Xuefeng Chen:1.Ultrasound Laboratory, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, China. ; 2.Ultrasound Department Yancheng No. 1 People's Hospital, Yancheng City, China. ; Xinyuan Zhang:1.Ultrasound Department Yancheng No. 1 People's Hospital, Yancheng City, China. ; Yangyang Qian:1.General Surgery Department, Yancheng No. 1 People's Hospital, Yancheng City, China. ; Enhui Xia:1.Ultrasound Department Yancheng No. 1 People's Hospital, Yancheng City, China. ; Yu Wang:1.Emergency Department, Yancheng No. 1 People's Hospital, Yancheng City, China. ; Qi Zhou:1.Ultrasound Laboratory, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, China. ;

  期刊：Ultrasound-targeted microbubble destruction-mediated miR-144-5p overexpression enhances the anti-tumor effect of paclitaxel on thyroid carcinoma by targeting STON2

  DOI：10.1080/15384101.2022.2040778

  影响因子 ：5.2

  引用产品： TPC-1 细胞 ,  FTC-133 细胞

• TEAD4 overexpression suppresses thyroid cancer progression and metastasis in vitro by modulating Wnt signaling (2012-01-20)

  作者：Buyong Zhang: 1.Department of Thyroid and Breast, Cangzhou Central Hospital, Cangzhou, China; Qingfeng Shi: 1.Department of Thyroid and Breast, Cangzhou Central Hospital, Cangzhou, China; Jie Li: 1.Department of Thyroid and Breast, Cangzhou Central Hospital, Cangzhou, China; Qingqing Wang: 1.Department of Gastroenterology, Cangzhou Central Hospital, Cangzhou, China; Yanting Ji: 1.Department of Thyroid and Breast (Nursing), Cangzhou Central Hospital, Cangzhou, China; Lingbo Xue: 1.Department of Thyroid and Breast (Nursing), Cangzhou Central Hospital, Cangzhou, China; Xuan Zhang: 1.Department of Administrative Center, Cangzhou Central Hospital, Cangzhou, China;

  期刊：TEAD4 overexpression suppresses thyroid cancer progression and metastasis in vitro by modulating Wnt signaling

  DOI：10.1007/s12038-021-00238-3

  影响因子 ：2.9

  引用产品： TPC-1 细胞 ,  FTC-133 细胞

• The Antitumour Effect of Prunella vulgaris Extract on Thyroid Cancer Cells In Vitro and In Vivo (2001-01-20)

  作者：Fangqin Yu:1.Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. ; 2.Key Discipline Laboratory of Clinical Medicine Henan, Zhengzhou, China. ; Lele Zhang:1.Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. ; 2.Key Discipline Laboratory of Clinical Medicine Henan, Zhengzhou, China. ; Runsheng Ma:1.Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. ; 2.Key Discipline Laboratory of Clinical Medicine Henan, Zhengzhou, China. ; Chenguang Liu:1.Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. ; 2.Key Discipline Laboratory of Clinical Medicine Henan, Zhengzhou, China. ; Qingduan Wang:1.Zhengzhou University, Academy of Medical and Pharmaceutical Sciences, Henan Key Laboratory for Pharmacology of Liver Diseases, Zhengzhou, China. ; Detao Yin:1.Department of Thyroid Surgery, The First Aff

  期刊：The Antitumour Effect of Prunella vulgaris Extract on Thyroid Cancer Cells In Vitro and In Vivo

  DOI：10.1155/2021/8869323

  影响因子 ：2.7

  引用产品： TPC-1 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞 ,  SW579 [SW 579; SW-579] 细胞 ,  FTC-133 细胞

• Activation of the TGF-β1/Smad signaling by KIF2C contributes to the malignant phenotype of thyroid carcinoma cells (2009-01-20)

  作者：Qiuyu Lin:1.Nuclear Medicine Department, The First Hospital of Jilin University, China. ; Qianle Qi:1.Nuclear Medicine Department, The First Hospital of Jilin University, China. ; Sen Hou:1.Nuclear Medicine Department, The First Hospital of Jilin University, China. ; Zhen Chen:1.Chengdu Xinke Pharmaceutical Co., LTD, China. ; Nan Jiang:1.Nuclear Medicine Department, The First Hospital of Jilin University, China. ; Laney Zhang:1.College of Biological Sciences, Cornell University, United States. ; Chenghe Lin:1.Nuclear Medicine Department, The First Hospital of Jilin University, China. Electronic address: linch@jlu.edu.cn. ;

  期刊：Activation of the TGF-β1/Smad signaling by KIF2C contributes to the malignant phenotype of thyroid carcinoma cells

  DOI：10.1016/j.tice.2021.101655

  影响因子 ：2.6

  引用产品： FTC-133 细胞

• Glypican 2 regulates cell proliferation and metastasis in thyroid cancer cells (2003-00-20)

  作者：Tao Zhang: 1.Department of Endocrinology and Metabolism, Lanzhou University Second Hospital, 82 Cuiyingmen Lanzhou, Lanzhou, 730030, Gansu, China; Xuan Ren: 1.Department of Endocrinology and Metabolism, Lanzhou University Second Hospital, 82 Cuiyingmen Lanzhou, Lanzhou, 730030, Gansu, China; Zhuan** Wang: 1.Department of Endocrinology and Metabolism, Lanzhou University Second Hospital, 82 Cuiyingmen Lanzhou, Lanzhou, 730030, Gansu, China; Yahong Liu: 1.Department of Pediatrics,Lanzhou University Second Hospital, 82 Cuiyingmen Lanzhou, Lanzhou, 730030, Gansu, China; Hongjuan Wang: 1.Department of Respiratory, Gansu Provincial People’s Hospital, 204 Donggang West Road, Lanzhou, 730000, Gansu, China;

  期刊：Glypican 2 regulates cell proliferation and metastasis in thyroid cancer cells

  DOI：10.1007/s13273-020-00073-x

  影响因子 ：1.7

  引用产品： 人甲状腺滤泡上皮细胞 ,  TPC-1 细胞 ,  FTC-133 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞 ,  NCI-H1563 细胞 ,  人甲状腺癌组织源细胞

点击展开收起列表